Literature DB >> 16442639

Capture of antigen-specific T lymphocytes from human blood by selective immortalization to establish long-term T-cell lines maintaining primary cell characteristics.

Eugene V Barsov1, Hanne Andersen, Vicky J Coalter, Mary Carrington, Jeffrey D Lifson, David E Ott.   

Abstract

To establish long-term, antigen-specific T-cell lines and clones, we selectively immortalized antigen-responsive T cells from human peripheral blood mononuclear cells (PBMCs). PBMCs were stimulated with either alloantigen or soluble antigen, then infected with a murine leukemia virus-based retroviral vector carrying an immortalizing gene, either the Tax gene from human T-cell leukemia virus type 1, or the human telomerase-reverse transcriptase gene. Since such vectors can only integrate in dividing cells, only antigen-activated T cells are efficiently transduced. This approach generated immortalized antigen-specific CD4+ and CD8+ T-cell lines that maintained strictly IL-2-dependent growth and HLA-restricted, antigen-specific responsiveness, some of which have been in continuous culture for longer than 1 year, far in excess of the survival of parallel control non-immortalized cultures. Clones derived from these lines showed antigen-specific proliferation with induced cytokine and chemokine production, and, in the case of a CD8+ T-cell clone, antigen-specific cytolytic activity. This approach provides a convenient, reproducible means for generating a stable, continuously renewable source of antigen-specific T lymphocytes for a variety of studies of T cell biology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16442639     DOI: 10.1016/j.imlet.2005.11.028

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  6 in total

1.  Immortalization of human and rhesus macaque primary antigen-specific T cells by retrovirally transduced telomerase reverse transcriptase.

Authors:  Eugene V Barsov
Journal:  Curr Protoc Immunol       Date:  2011-11

2.  Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene.

Authors:  Cary Hsu; Stephanie A Jones; Cyrille J Cohen; Zhili Zheng; Keith Kerstann; Juhua Zhou; Paul F Robbins; Peter D Peng; Xinglei Shen; Theotonius J Gomes; Cynthia E Dunbar; David J Munroe; Claudia Stewart; Kenneth Cornetta; Danny Wangsa; Thomas Ried; Steven A Rosenberg; Richard A Morgan
Journal:  Blood       Date:  2007-03-12       Impact factor: 22.113

Review 3.  Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy.

Authors:  Eugene V Barsov
Journal:  Immunotherapy       Date:  2011-03       Impact factor: 4.196

4.  GM-CSF production allows the identification of immunoprevalent antigens recognized by human CD4+ T cells following smallpox vaccination.

Authors:  Valeria Judkowski; Alcinette Bunying; Feng Ge; Jon R Appel; Kingyee Law; Atima Sharma; Claudia Raja-Gabaglia; Patricia Norori; Radleigh G Santos; Marc A Giulianotti; Mark K Slifka; Daniel C Douek; Barney S Graham; Clemencia Pinilla
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

5.  Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques.

Authors:  Daniel Mendoza; Stephen A Migueles; Julia E Rood; Bennett Peterson; Sarah Johnson; Nicole Doria-Rose; Douglas Schneider; Eva Rakasz; Matthew T Trivett; Charles M Trubey; Vicky Coalter; Claire W Hallahan; David Watkins; Genoveffa Franchini; Jeffrey D Lifson; Mark Connors
Journal:  PLoS Pathog       Date:  2013-02-28       Impact factor: 6.823

6.  A humanized mouse model of autoimmune insulitis.

Authors:  Ashley A Viehmann Milam; Stephen E Maher; Joanna A Gibson; Jasmin Lebastchi; Li Wen; Nancy H Ruddle; Kevan C Herold; Alfred L M Bothwell
Journal:  Diabetes       Date:  2014-01-29       Impact factor: 9.461

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.